動物用藥品化合物市場：依藥物類別、動物類型、劑型和地區

2025年全球動物用藥品化合物市場規模估計為 22.9億美元，預計到2032年將達到 42.2億美元，2025-2032年的年複合成長率（CAGR）為 9.1%。

圖表.2025年動物用藥品化合物市場佔有率（依地區）

動物用藥品可根據個別動物患者的需要定製藥物製劑，在動物保健中發揮重要作用。當 FDA核准的藥物不存在患者所需的適當強度或劑型時，最常使用它們。組合藥物允許獸醫根據寵物的大小、年齡、醫療狀況和其他因素制定定製藥物和劑量。這種靈活的藥物治療方法可以幫助改善許多動物的治療效果。

市場動態：

全球動物用藥品化合物市場的成長受到過去幾年寵物擁有率上升和寵物照護支出增加等因素的推動。寵物飼主對為寵物提供客製化醫療照護的意識不斷增強，推動了市場的成長。然而，複方藥物缺乏監管和品質標準，帶來安全風險，並可能阻礙市場成長。劑量和組合藥物配方的靈活性等優勢為市場參與者提供了有利的機會。 FDA 最近發布的加強這些設施品質監督的指導方針可能會推動市場成長。

本研究的主要特點

• 本報告對全球動物用藥品化合物市場進行了詳細分析，以2024年為基準年，並提供了預測期（2025-2032年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
• 提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 全球動物用藥品化合物市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球動物用藥品化合物市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過用於分析全球動物用藥品化合物市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

• 市場動態
  • 促進因素
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管情景
• 收購與合作場景
• 資金籌措與投資
• PEST分析
• 波特的分析

第4章 全球動物用藥品化合物市場-冠狀病毒（COVID-19）大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

第5章 2020-2032年全球動物用藥品化合物市場（依藥物類別）（十億美元）

• 中樞神經系統藥物
• 抗感染劑
• 荷爾蒙和替代品
• 抗發炎劑
• 其他

第6章 2020-2032年全球動物用藥品化合物市場（按動物類型）（十億美元）

• 寵物
• 狗
• 貓
• 其他
• 家畜

第7章 全球動物用藥品化合物市場，依配方，2020-2032年（十億美元）

• 口服
• 注射
• 其他

第8章 2020-2032年全球動物用藥品化合物市場（依地區）（十億美元）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Wedgewood Pharmacy
  • Diamondback Drugs LL
  • Stokes Pharmacy
  • MEDISCA
  • Patterson Companies, Inc.
  • Boehringer Ingelheim
  • Zoetis Inc.
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck &Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol SA
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

第10章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法

Global Veterinary Drugs Compounding Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 4.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Figure. Veterinary Drugs Compounding Market Share (%), By Region 2025

Compounded medications play an important role in veterinary medicine by allowing for customized medication preparations tailored to individual animal patients' needs. These are most commonly used when an FDA-approved drug may not exist in the appropriate strength or dosage form required for a patient. Compounded drugs allow veterinarians to create customized medications and doses depending on factors like pet's size, age, or medical condition. This flexible approach to medication can help improve treatment outcomes for many animals.

Market Dynamics:

Global veterinary drugs compounding market growth is driven by factors such as rising pet ownership and increased spending on pet care over the past few years. Growing awareness among pet owners about providing customized medical care to their animals can drive the market growth. However, lack of regulation and quality standards for compounded drugs poses safety risks and can hamper the market growth. Advantages like flexibility in dosages and forms for compounded drugs present lucrative opportunities for market players. Recent FDA guidelines to strengthen quality oversight of these facilities could drive the market growth.

Key features of the study:

• This report provides in-depth analysis of the global veterinary drugs compounding market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary drugs compounding market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Patterson Veterinary, Chase Pharmaceuticals, Kentucky Performance Products, Animal Medics and Rx3 Compounding
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global veterinary drugs compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary drugs compounding market.

Detailed Segmentation-

• By Drug Class
  • CNS Agents
  • Anti-infective Agents
  • Hormones and Substitutes
  • Anti-inflammatory Agents
  • Others
• By Animal Type
  • Companion Animals
  • Dogs
  • Cat
  • Others
  • Livestock Animals
• By Formulation
  • Oral
  • Injectable
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Wedgewood Pharmacy
  • Diamondback Drugs LL
  • Stokes Pharmacy
  • MEDISCA
  • Patterson Companies, Inc.
  • Boehringer Ingelheim
  • Zoetis Inc.
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Formulation
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Veterinary Drugs Compounding Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Veterinary Drugs Compounding Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• CNS Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-infective Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hormones and Substitutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-inflammatory Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Veterinary Drugs Compounding Market, By Animal Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Companion Animals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dogs
• Cat
• Others
• Livestock Animals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Veterinary Drugs Compounding Market, By Formulation, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injectable
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Veterinary Drugs Compounding Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Wedgewood Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Diamondback Drugs LL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stokes Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MEDISCA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Patterson Companies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

10. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact